Hospital das Clinicas - Universidade Federal de Minas Gerais
Belo Horizonte, Minas Gerais, 30130100, Brazil
NCT Number: NCT01975649
Hypoactive Sexual Desire Disorder ( HSDD ) is very common in postmenopausal women due to a reduction in circulating androgen levels. The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD.
Looking for future studies?
Notify Me50 year–65 year
Female
Interventional
Phase 4
Belo Horizonte, Minas Gerais, 30130100, Brazil
Hypoactive Sexual Desire Disorder ( HSDD ) is the most prevalent female sexual dysfunction in society mainly in postmenopausal women, and is strongly linked to the quality of life of women . The androgen hormones decline over age in the premenopausal period, more sharply after menopause. Tribulus terrestris is a plant native to India , recommended in the treatment of infertility , low libido and impotence . Its main active ingredient is the protodioscin , which has been attributed to an increase in testosterone levels and improved sexual function . The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients will use 750 mg/day during 120 days
Other names: tribulus
patients will use placebo pills with the same shape of the drug
Time frame: 120 days
we will use the "Quotient Sexual - Version Feminine (QS-F) brazilian questionary to make the evaluation
Time frame: 120 days
Blood test
Time frame: 120 days
Blood test
Federal University of Minas Gerais
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06539897
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Antalya, Turkey (Türkiye)
View Trial DetailsNCT03116022
Dyspareunia, Female Urogenital Diseases
Ribeirão Preto, São Paulo, Brazil
View Trial DetailsNCT02430987
Body Weight, Genital Diseases
São Paulo, Brazil
View Trial DetailsNCT05312099
Behavior, Behavioral Symptoms
Çorum, Turkey (Türkiye)
View Trial Details